Navigation Links
FDA Approves INTELENCE(TM) (etravirine) for HIV Combination Therapy
Date:1/18/2008

[p<0.0001].

-- Significantly greater mean increase in CD4+ cell count from baseline;

mean increase of 81 vs. 64 cells/mm(3)[p=0.0022]

The results of DUET-1 and DUET-2 were published separately in two articles in the July 7, 2007 issue of The Lancet, and the pooled analysis from the DUET studies was presented at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in September 2007.

DUET-1 and -2 Resistance

-- The presence of K103N, which was the most prevalent NNRTI substitution

in DUET-1 and -2 studies at baseline, did not affect the response in

the INTELENCE arm.

-- The presence at baseline of the substitutions V179D, V179F, V179T,

Y181V, or G190S was associated with a decreased virologic response to

INTELENCE.

-- In the DUET-1 and -2 studies, the presence at baseline of three or more

2007 IAS-USA-defined NNRTI substitutions (V90I, A98G, L100I, K101E/P,

K103N, V106A/I/M, V108I, V179D/F, Y181C/I/V, Y188C/H/L, G190A/S, P225H)

resulted in a decreased virologic response to INTELENCE.

-- For patients in the DUET-1 and -2 studies experiencing virologic

failure on an INTELENCE-containing regimen, the substitutions that

occurred most commonly were V179F, V179I, Y181C, and Y181I which

usually emerged in a background of multiple other NNRTI

resistance-associated substitutions. Other NNRTI resistance-associated

substitutions which emerged in patients on INTELENCE treatment in

< 10 percent of the virologic failure isolates included K101E, K103N,

V106I/M, V108I, Y188L, V189I, G190S/C and R356K.

-- Cross-resistance to delavirdine, efavirenz, and/or nevirapine is

expected after virologic failure with an INTELENCE-containing regimen.

DUET-1 and -2 Tolerability

In the DUET-1 and -2 studies, the most common adverse events (> 10 percent) o
'/>"/>

SOURCE Tibotec Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
2. FDA Approves New Mechanism of Action Labeling for Ranexa(R)
3. FDA Approves Diovan(R) for Treatment of High Blood Pressure in Children
4. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) as the First Medication for Add-On Treatment of Major Depressive Disorder (MDD)
5. FDA Approves New SPRYCEL(R) (Dasatinib) Product Labeling for Patients with Chronic-Phase CML
6. FDA Approves Genzymes Renvela(TM) for Dialysis Patients
7. FDA Approves IXEMPRA(TM) (ixabepilone), a Semi-Synthetic Analog of Epothilone B, for the Treatment of Advanced Breast Cancer
8. FDA Approves DORIBAX(TM) for the Treatment of Complicated Intra-Abdominal and Complicated Urinary Tract Infections
9. FDA Approves Administration of LEXIVA(R) with Lower Dose of Boosting Medication Ritonavir
10. FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R) (clopidogrel bisulfate)
11. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Mass. , Jan. 14, 2014  RXi Pharmaceuticals ... discovering, developing and commercializing innovative therapies addressing major ... that it received the Notice of Allowance from ... its unique self-delivering RNAi compounds (sd-rxRNA®), for the ...
(Date:1/14/2014)... ®, provider of RapidResponse ®, a cloud-based supply chain ... S&OP ) service, is proud to be a gold sponsor ... at the Hilton San Diego Bayfront, January 30 – 31, ... , Director of Supply Chain at Amgen, as she presents ...
(Date:1/14/2014)... January 14, 2014 Kerr Corporation, a leading ... and additional how-to information about dual arch impressions on its ... Dual Arch Impressions,” the blog entry serves up a list ... houses a step-by-step demonstration by Dr. David Little as he ...
(Date:1/14/2014)... CA (PRWEB) January 14, 2014 Independent ... County), California, and Montreal, Canada, has big ideas for ... non-fiction. The press's goals are to produce high-quality, low-cost, ... to support local businesses. , The first major ...
Breaking Biology Technology:RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2Bitingduck Press Looks Forward to 2014 With Multimedia E-books 2
... CHICAGO, Nov. 29, 2011 Compressus today introduced the ... workflow solutions with the release of the MEDxConnect™ System ... release features a highly flexible platform that empowers users ... market challenges. The Company made the announcement here shown ...
... Calif., Nov. 29, 2011 GeneTex, a leading ... is pleased to announce that they will be ... and Hec1. Both of these targets are key ... http://photos.prnewswire.com/prnh/20111129/LA13485-a ) (Logo:   http://photos.prnewswire.com/prnh/20111129/LA13485LOGO-b ...
... A*STAR Singapore took lead roles in a study that ... culture of human embryonic stem cells (hESCs). The study ... of the University of Sheffield (UK), Paul Robson of ... Singapore,s Bioprocessing Technology Institute (BTI), and Barbara Knowles and ...
Cached Biology Technology:Compressus Drives Programmable Workflow And Unprecedented Flexibility With Introduction of MEDxConnect™ v4.0 2Compressus Drives Programmable Workflow And Unprecedented Flexibility With Introduction of MEDxConnect™ v4.0 3Compressus Drives Programmable Workflow And Unprecedented Flexibility With Introduction of MEDxConnect™ v4.0 4GeneTex Antibody Company to Launch New Line of Primary Antibodies for the Study of Spindle Assembly 2GeneTex Antibody Company to Launch New Line of Primary Antibodies for the Study of Spindle Assembly 3Singapore scientists lead human embryonic stem cell study 2Singapore scientists lead human embryonic stem cell study 3
(Date:4/16/2014)... legal, artisanal green sea turtle fishery has uncovered a ... in what may have become an unsustainable take, according ... University of Florida. , During the research period, conservation ... killed between 1991 and 2011, with catch rates peaking ...
(Date:4/16/2014)... Armand-Frappier has just received a research grant from the National ... The 5-year grant is to pursue cutting-edge research in the ... biomedical potential in the field of oncology as well as ... at this level is an accomplishment in itself," said Yves ...
(Date:4/16/2014)... all of our movements, thoughts and feelings are the ... have suggested that some of the conversations might not be ... listening in on, or even participating in, some of those ... only be tuning in part of the time specifically, ...
Breaking Biology News(10 mins):Declining catch rates in Caribbean green turtle fishery may be result of overfishing 2Declining catch rates in Caribbean green turtle fishery may be result of overfishing 3High-level NIH grant goes to professor Nicolas Doucet of INRS 2Eavesdropping on brain cell chatter 2Eavesdropping on brain cell chatter 3
... that voting decisions are more associated with the ... appearance than to positive ones, says a team ... (Caltech), Scripps College, Princeton University, and the University ... when voters have little or no information about ...
... male partner is on your case. In fact, he ... kept to the straight and narrow. The flip side ... be better than men at concealing illicit liaisons., Paul ... gave 203 young heterosexual couples confidential questionnaires asking them ...
... Deane Evans will provide an introduction to the basics of building ... to the public, at NJIT. The talk, set for Nov. ... of the status of the NJ schools, construction program. ... Evans, a registered architect, is executive director of NJIT,s ...
Cached Biology News:Caltech-led researchers find negative cues from appearance alone matter for real elections 2Caltech-led researchers find negative cues from appearance alone matter for real elections 3Caltech-led researchers find negative cues from appearance alone matter for real elections 4Men are better at detecting infidelities 2
... long and short-term enriched housing for nonhuman ... quarantine and non-quarantine settings on a per ... utilizing our state-of-the-art social housing and nursery ... on site CDC quarantine facilities. Primate ...
... gel stain has bright fluorescence when bound to ... ideal for detecting dsDNA in gels using laser ... I nucleic gel acid stain has also ... and bandshift assays. One mL stains 100 minigels. ...
Eagle's Ham's amino acids; EHAA...
... IRsolution software provides quick and easy operation ... with Windows-based control. The software is ... FDA 21 CFR Part 11 regulations, and ... measurement. IRsolutions versatility enables use in ...
Biology Products: